Functional food in elderly persons;Bedeutung von functional food in der geriatrie

Therapeutische Umschau

Volumn 64, Issue 3, 2007, Pages 141-146

  Sieber, Cornel C ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LACTULOSE; PROBIOTIC AGENT; VITAMIN D;

BIFIDOBACTERIACEAE; BREAST CANCER; CANCER PREVENTION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DIET SUPPLEMENTATION; DOSE RESPONSE; ELDERLY CARE; EVIDENCE BASED MEDICINE; FRAIL ELDERLY; FUNCTIONAL FOOD; GERIATRIC NUTRITION; HUMAN; IMMUNE SYSTEM; IMMUNITY; META ANALYSIS; MUSCLE ATROPHY; NUTRITIONAL DISORDER; NUTRITIONAL FRAILTY; OSTEOPOROSIS; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; SACCHAROMYCES BOULARDII; SYSTEMATIC REVIEW;

AGED; AGED, 80 AND OVER; DIET THERAPY; DIETARY SUPPLEMENTS; FEMALE; FOOD, FORMULATED; FOOD, FORTIFIED; HEALTH FOOD; HUMANS; MALE; NUTRITION PHYSIOLOGY;

EID: 33947280384     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.64.3.141     Document Type: Review

References (64)

1. Kollath W. Ernährung und Zahnsystem. Deutsche Zahnärzte Z 1953; 8: 7-16.
2. Ferrari CK. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology 2004; 5: 275-89.
3. Gibson GR, Roberfoid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
4. Rastall RA, Gibson GR. Prebiotic oligosaccharides: evaluation of biological activities and potential future developments. In: Tannack GW ed. Probiotics and prebiotics: where are we going? Wymondham: Caister Academic Press, 2002: 149-17.
5. Hamilton-Miller JM. Probiotics and prebiotics in the elderly. Postgrad Med J 2004; 80: 447-51.
6. Pelletier DL. Science, law, and politics in FDA's genetically engineered foods policy: scientific concerns and uncertainties. Nutr Rev 2005; 63: 210-23.
7. Hauswirth CB, Scheeder MRL, Beer JH. Ist Schweizer Alpkäse Functional Food? Aktuel Ernaehr Med 2006; 31: 13-7.
8. Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, Blair M, Walston JD. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004; 16: 153-7.
9. Ferrucci L, Guralnik JM, Studenski S, Fried L, Cutler GB JR, Walston JD. Interventions of Frailty Working Group. J Am Geriatr Soc 2004; 52: 625-34.
10. Muhlberg W, Sieber C. Sarcopenia and frailty in geriatric patients: implications for training and prevention. Z Gerontol Geriatr 2004; 37: 2-8.
11. Volkert D, Berner YN, Berry E, Cederholm T, Coti Betrand P, Milne A, et al. ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr 2006; 25: 330-60.
12. Thomas DR. Vitamins in health and aging. Clin Geriatr Med 2004; 20: 259-74.
13. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP. Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidites: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-41.
14. Dirks AJ, Leeuwenburgh C. Tumor necrosis factor alpha signaling in skeletal muscle: effects of age and caloric restriction. J Nutr Biochem 2006; 17: 501-8.
15. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119: 9-17.
16. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, et al. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 2006; 184 (Suppl 4): S4-S24.
17. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21: 495-505.
18. Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56: M158-M166.
19. Bales CW, Ritchie CS. Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu Rev Nutr 2002; 22: 309-23.
20. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999; 107: 123-36.
21. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004; 12: 887-8.
22. Greenlund LJ, Nair KS. Sarcopenia - consequences, mechanisms, and potential therapies. Mech Ageing Dev 2003; 124: 287-99.
23. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 2006; 54: 56-62.
24. Johnson MA, Kimlin MG. Vitamin D, aging, and the 2005 Dietary Guidelines for Americans. Nutr Rev 2006; 64: 410-21.
25. Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004; 80 (Suppl 6): 1710S-16S.
26. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol 2006; 92: 33-8.
27. Cashman K. Prebiotics and calcium bioavailability. In: Tannack GW ed. Probiotics and prebiotics: where are we going? Wymondham: Caister Academic Press, 2002: 107-48.
28. Van den Heuvel EG, Schoterman MH, Muijs T. Transgalactooligosaccharides stimulate calcium absorption in post-menopasal women. J Nutr 2000; 130: 2938-42.
29. Norman AW. Vitamin D Receptor (VDR): New assignments for an already busy receptor. Endocrinology 2006; 31: (Epub ahead of print).
30. Campbell PM, Allain TJ. Muscle strength and Vitamin D in older people. Gerontology 2006; 52: 335-8.
31. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Nutr 2002; 75: 611-5.
32. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, Allain TJ. Vitamin D supplementation improves neuromuscular function in older people with fall. Age Ageing 2004; 33: 589-95.
33. Boonen S, Bischoff-Ferrari HA, Cooper C, Lips P, Ljunggren O, Meunier PJ, Reginster JY. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 2006; 78: 257-70.
34. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994; 35 (Suppl 1): S35-S8.
35. Husebye E. The stimulatory influence of the intestinal microflora on gastrointestinal motility and myoelectric activity of small intestine. In: Heidt PJ, Rusch V, van der Waaij D eds. Gastro-intestinal motility. Old Herborn University Seminar Monographs #9. Herborn: Herborn Litterae, 1997: 41-52.
36. Ouwehand AC, Lagstrom H, Suomalainen T, Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 2002; 46: 159-62.
37. Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol 1997; 32 (Suppl 222): 45-8.
38. Rajala SA, Salminen SJ, Seppanen JH, Vapaatalo H. Treatment of chronic constipation with lactilol sweetened yoghurt supplemented with guar gum and wheat brain in elderly hospital in-patients. Compr Gerontol 1988; 2: 83-6.
39. Teuri U, Korpela R. Galacto-oligosaccharides relieve constipation in elderly people. Ann Nutr Metab 1998; 42: 319-27.
40. Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in the elderly constipated persons. Am J Clin Nutr 1997; 65: 1397-402.
41. Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis 2002; 34 (Suppl 2): S12-S8.
42. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment Pharmacol Ther 2005; 15: 495-512.
43. Foligne B, Senegas-Balas F, Antoine JM, Cayuela C, Rolf-Pedersen N, Balas D. Trophic status of the small intestine in young and aged rats: modulation by a yogurt-supplement diet. Dig Dis Sci 2004; 49: 1291-301.
44. Del Piano M, Ballare M, Montino F, Orsello M, Garello E, Ferrari P, Masini C, Strozzi GP, Sforza F. Clinical experience with probiotics in the elderly on total enteral nutrition. J Clin Gastroenterol 2004; 38 (Suppl 6): S11-S114.
45. Saavedra JM, Tschernia A. Human studies with probiotics and prebiotics: clinical implications. Br J Nutr 2002; 87 (Suppl 2): S241-S6.
46. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.
47. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361-4.
48. Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q, Harris-White ME, Frautschy SA. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging 2005; 26 (Suppl 1): 133-6.
49. Alan DD, Clemens F, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Huppert FA, Knight R, Letley L, Richards M, Truesdale A, Vickers M, Uauy R. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol (ISRCTN 72331636). Nutr J 2006; 31: 5-20.
50. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 2005; 62: 1849-53.
51. Morris MC, Evans DA, Bienias JL, Trangney CC, Wilson RS. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59: 1125-32.
52. Saugstad LF. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr Health 2006; 18: 89-101.
53. Kitani K, Yokozawa T, Osawa T. Intervention in aging and age-associated pathologies by means of nutritional approaches. Ann N Y Acad Sci 2004; 1019: 424-6.
54. Hulbert AJ, Faulks SC, Harper JM, Miller RA, Buffenstein R. Extended longevity of wild-derived mice is associated with peroxidation-resistant membranes. Mech Ageing Dev 2006; 127: 653-7.
55. De Llanos R, Querol A, Peman J, Gobernado M, Fernandez-Espinar MT. Food and probiotic strains from Saccharomyces cerevisiae species as possible origin of human systemic infections. Int J Food Microbiol 2006; 110: 286-90.
56. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006; 83: 125-1264.
57. Gill HS, Rutherfrd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001; 74: 833-9.
58. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001; 21: 264-71.
59. Guigoz Y, Rochat F, Perruisseau-Carrier G. Effects of oligosaccharides on the faecal flora and non-specific immune system in elderly people. Nutr Res 2002; 22: 13-25.
60. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-113001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003; 7: 75-77.
61. Marteau PR. Probiotics in clinical conditions. Clin Rev Allergy Immunol 2002; 22: 255-73.
62. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 2002; 82: 279-89.
63. Teitelbaum JE, Walker WA. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Ann Rev Nutr 2002; 22: 107-38.
64. Rowland IR. Gut microflora and cancer. In: Leeds AR, Rowland IR eds. Gut flora and Health - past, present and future. International Congress and Symposium Series, No 219. London: Royal Society of Medicine Press, 1996: 19-25.